The 1st Alzheimer’s Disease Research Center in South Texas Will Tackle Dementia in Latinos


latino alzheimer's disease dementia tweetchat brain healthAlzheimer’s Disease Research Cente Alzheimer’s Disease Research Center

Today, the National Institute on Aging (NIA) of the National Institutes of Health (NIH) designated UT Health San Antonio and UT Texas Rio Grande Valley as an Alzheimer’s Disease Research Center to boost research and reduce the Alzheimer's burden among Latinos, who suffer disparities in dementia. The new center is the first in South Texas. It joins 32 other centers nationwide that are accelerating research on effective Alzheimer’s and dementia prevention, diagnostics, and treatments, and improving support for families and caregivers. Salud America! is a center partner to promote its research and clinical trials. "This federal designation by NIA will be transformational as we seek cures and provide the best possible care, based on the most up-to-date knowledge and technology, ...

Read More

#SaludTues Tweetchat 10/5: Importance of Latino Participation in Clinical Trials in Alzheimer’s Disease


hispanic abuela grandmother with dementia alzheimers clinical trials

Sadly, Latinos are 1.5 times more likely to develop Alzheimer’s disease than whites. Across the board, Latinos are underrepresented in clinical research. Without Latino representation in Alzheimer's clinical trials, researchers cannot find treatments that work best for this population. Researchers also must understand and address the differential role of Alzheimer's among Latinos, and the impact of alcohol, sleep deprivation, diabetes, and more. Let’s use #SaludTues on Tuesday, Oct. 5, 2021, to tweet about the latest research and beneficial strategies and clinical trials to reduce Alzheimer's disease and promote better brain health among Latinos and all people! WHAT: #SaludTues: Importance of Latino Participation in Clinical Trials in Alzheimer’s Disease TIME/DATE: ...

Read More

Combat COVID: Promoting Clinical Trials to Help Fight COVID-19


combat covid clinical trial masks for covid-19

Combat COVID is a federal education initiative to share bilingual information and tips about vaccines, potential treatments, and clinical trials for COVID-19. A clinical trial is a research study to find a new treatment or achieve a better understand a disease. In the case of COVID-19, which has overly burdened Latinos and Blacks, clinical trials need more participants of color to ensure that COVID-19 treatments are effective for everyone. "Clinical trials are at the heart of many medical discoveries," according to the team at Combat COVID, run by the U.S. Department of Health and Human Services. "[Trials] are the key to protecting our communities now and in the future." Let's take a look at the work Combat COVID is doing. Promoting Clinical Trails for COVID-19 Combat COVID ...

Read More

Webinar 9/23/21: Metastatic Breast Cancer in the Latino Community


Breast Cancer Latino Community

Breast cancer is the leading cause of death in Latinas. Systemic health inequities contribute to lower rates of breast cancer screening among Latinos, which leads to cancer diagnoses at later disease stages. This is why we're sharing Susan G. Komen’s 2021 ongoing webinar series on metastatic breast cancer (MBC)! The next two webinars, "MBC in the Hispanic/Latino Community," are set for 6 p.m. CT Sept. 23, 2021, in English and 6 p.m. CT Sept. 30, 2021, in Spanish. Panelists are: Dr. Filipa Lynce, Dana-Farber Cancer Institute, Director, Inflammatory Breast Center, Harvard Medical School. Dr. Jose Pablo Leone, Dana-Farber Cancer Institute, Director, Program for Breast Cancer in Men, Harvard Medical School Panelists will foster a safe, collaborative space to discuss ...

Read More

Elsada Wilson: Amid Breast Cancer, Finding Hope Through a Clinical Trial


Elsada Wilson Breast Cancer Clinical Trial

Cancer is a tough, scary, life-threatening journey, especially for women of color. That is why researchers conduct clinical trials, which are studies to find more effective treatments or achieve a better understand breast cancer and survival among minorities. But, to make progress, clinical trials need diverse volunteers – like Elsada Wilson. Wilson joined a clinical trial at Mays Cancer Center at UT Health San Antonio and found hope for herself, her family, and the future. “I felt like I was helping further studies and knowledge,” she said. If it helps me then I'll be able to help my family and help other people that need help. I wanted to help others. I said to myself, ‘It might be that small thing that might help another person.’ Right?” Wilson’s Breast ...

Read More

Join the AHEAD Clinical Trial to Help Our Familias Prevent Memory Decline!


AHEAD Clinical Trial Familias Prevent Memory Decline

Latinos are 1.5 times more likely to develop Alzheimer’s than their white peers. Its why diversity in clinical trials is absolutely critical. Fortunately, those studies can help us fight back against Alzheimer’s. If you are age 55 to 80, you can volunteer for the AHEAD Clinical Trial that aims to protect against the onset of Alzheimer's disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. “I got involved with the AHEAD clinical trial because both of my parents had Alzheimer’s,” Dave Ralberer, an AHEAD study participant and study partner, said. “My mother was 72 when she passed away. My dad has been struggling with the disease for 13 years. I have the unusual opportunity to be working with ...

Read More

Health Care Workers: Find If You Have Implicit Bias & What to Do Next!


healthcare provider team dealing with implicit bias 2

Doctors have implicit, subconscious preferences for white patients over those of color, studies show. This is implicit bias. These biases — stereotypes that affect our understanding and decisions about others beyond our conscious control — lead to discrimination and health disparities. Fortunately, implicit bias can be “rewired” for compassion for patients of color. Download the free Salud America! Action Pack “Health Care Workers and Researchers: Find If You Have Implicit Bias and What to Do Next.” This Action Pack will help you see if you have implicit bias, learn from others who have overcome their own implicit bias, and encourage colleagues to learn about implicit bias, to," said Dr. Amelie G. Ramirez, director of the Salud America! Latino health equity ...

Read More

Emelina Asto-Flores: Participant in a COVID-19 Vaccine Clinical Trial to Help Latinos!


Vaccine Clinical Trial Latinos

Why did Emelina Asto-Flores volunteer for a clinical trial to test a COVID-19 vaccine? Asto-Flores, a community health educator in Florida, saw how the pandemic devastated Latinos, and she decided to enroll in the trial to help her people. Not only did she help researchers make sure the vaccine is safe for Latinos, but the trial also gave her the knowledge and confidence to encourage others to get their shot. “Representation is important in a clinical trial,” Asto-Flores said. “You wouldn't want a clinical trial to be just consisted of one group. These results need to be proportionate to our diverse communities. It's so important for us as members of the [Latino] community to take that leadership role that could save lives. So those that are a part of that can say, ...

Read More

Join the REACH Clinical Trial to Help Slow Alzheimer’s for Our Familias!


REACH trial graphic 1

Alzheimer’s disease hurts the quality of life of many of our beloved abuelos and abuelas, their family members, and caregivers. Fortunately, clinical trials can help us fight back against Alzheimer’s. You or your loved ones can volunteer for the REACH Clinical Trial that aims to slow the effects of Alzheimer’s disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. REACH Clinical Trial volunteers will be reimbursed up to $100 for each trial visit. “Our mission is to provide a compassionate and comprehensive network of clinical care for patients and their families with access to the most advanced treatment in clinical trials, as we continue to lead the search for a cure for Alzheimer’s and ...

Read More